0001193125-26-212109
SEC filingHyperliquid Strategies Inc reported Q3 FY2026 net profit of $152.5 million driven by $198.4 million unrealized HYPE token gains, with treasury expanded to 20.0 million HYPE tokens and $103 million cash as of April 29, 2026.
Hyperliquid Strategies Inc's Q3 results showcased a dramatic turnaround to $152.5 million net profit, primarily fueled by $198.4 million in unrealized gains on HYPE tokens at a quarter-end price of $36.60, partially offset by a $42.7 million deferred tax expense increase. This contrasts sharply with the nine-month net loss of $165.4 million, driven by $64.0 million in prior HYPE unrealized losses, a one-time $35.6 million IPR&D write-off from the legacy Sonnet acquisition, and $60.5 million deferred tax expense. Staking revenue reached $2.6 million in Q3 from HYPE holdings, underscoring the treasury strategy's yield generation amid Hyperliquid ecosystem growth. CEO David Schamis highlighted treasury scaling to 20.0 million HYPE tokens (as of April 29), validator partnership with Unit, and disposition of legacy bio-tech operations, aligning HSI with Hyperliquid's deflationary mechanics, HIP-3 RWA perps, portfolio margin, and outcome markets. The strong balance sheet with $809.4 million assets, $113.1 million cash, $689.0 million HYPE (18.83 million tokens), and no debt supports disciplined capital deployment: $216 million for HYPE accumulation and $10.5 million for 3.0 million PURR share repurchases at $3.42 average. Investors should monitor the website's Adjusted Net Asset Value and upcoming 10-Q for full details, with a webcast held on May 7 providing further management insights.